Rosamaria Lappano (Marcello Maggiolini)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 15

Top Topics

Endoplasmic Reticulum

Top Venues

International journal of molecular sciences

Expert opinion on therapeutic targets

This page only lists publications with an associated author ORCID identifier.

Publications

Maria Antonietta Occhiuzzi, Giuseppina Ioele, Michele De Luca, Bruno Rizzuti, Domenica Scordamaglia, Rosamaria Lappano, Marcello Maggiolini, Antonio Garofalo, Fedora Grande
Dissecting CYP1A2 Activation by Arylalkanoic Acid Prodrugs toward the Development of Anti-Inflammatory Agents. International journal of molecular sciences 25 (1) (2023)
Rosamaria Lappano, Marcello Maggiolini
Role of the G Protein-Coupled Receptors in Cancer and Stromal Cells: From Functions to Novel Therapeutic Perspectives. Cells 12 (4) (2023)
Marilena Kampa, Rosamaria Lappano, Fedora Grande, Bruno Rizzuti, Marcello Maggiolini, Elias Castanas, Yves Jacquot
Promising Perspectives of the Antiproliferative GPER Inverse Agonist ERα17p in Breast Cancer. Cells 12 (4) (2023)
Rosamaria Lappano, Marcello Maggiolini
Role of the G Protein-Coupled Receptors in Cancer and Stromal Cells: From Functions to Novel Therapeutic Perspectives. Cells 12 (4) (2023)
Maria Antonietta Occhiuzzi, Giuseppina Ioele, Michele De Luca, Bruno Rizzuti, Domenica Scordamaglia, Rosamaria Lappano, Marcello Maggiolini, Antonio Garofalo, Fedora Grande
Dissecting CYP1A2 Activation by Arylalkanoic Acid Prodrugs toward the Development of Anti-Inflammatory Agents. International journal of molecular sciences 25 (1) (2023)
Ernestina Marianna De Francesco, Rosaria Valentina Rapicavoli, Rosario Le Moli, Rosamaria Lappano, Andrea Morrione, Ernestina Marianna De Francesco, Veronica Vella
IGF2: A Role in Metastasis and Tumor Evasion from Immune Surveillance? Biomedicines 11 (1) (2023)
Marilena Kampa, Rosamaria Lappano, Fedora Grande, Bruno Rizzuti, Marcello Maggiolini, Elias Castanas, Yves Jacquot
Promising Perspectives of the Antiproliferative GPER Inverse Agonist ERα17p in Breast Cancer. Cells 12 (4) (2023)
Ernestina Marianna De Francesco, Rosaria Valentina Rapicavoli, Rosario Le Moli, Rosamaria Lappano, Andrea Morrione, Ernestina Marianna De Francesco, Veronica Vella
IGF2: A Role in Metastasis and Tumor Evasion from Immune Surveillance? Biomedicines 11 (1) (2023)
Rosamaria Lappano, Marcello Maggiolini
Role of the G Protein-Coupled Receptors in Cancer and Stromal Cells: From Functions to Novel Therapeutic Perspectives. Cells 12 (4) (2023)
Maria Antonietta Occhiuzzi, Giuseppina Ioele, Michele De Luca, Bruno Rizzuti, Domenica Scordamaglia, Rosamaria Lappano, Marcello Maggiolini, Antonio Garofalo, Fedora Grande
Dissecting CYP1A2 Activation by Arylalkanoic Acid Prodrugs toward the Development of Anti-Inflammatory Agents. International journal of molecular sciences 25 (1) (2023)
Ernestina Marianna De Francesco, Rosaria Valentina Rapicavoli, Rosario Le Moli, Rosamaria Lappano, Andrea Morrione, Ernestina Marianna De Francesco, Veronica Vella
IGF2: A Role in Metastasis and Tumor Evasion from Immune Surveillance? Biomedicines 11 (1) (2023)
Marilena Kampa, Rosamaria Lappano, Fedora Grande, Bruno Rizzuti, Marcello Maggiolini, Elias Castanas, Yves Jacquot
Promising Perspectives of the Antiproliferative GPER Inverse Agonist ERα17p in Breast Cancer. Cells 12 (4) (2023)
Ernestina Marianna De Francesco, Francesca Cirillo, Veronica Vella, Ernestina Marianna De Francesco, Marcello Maggiolini, Rosamaria Lappano
Triple-negative breast cancer drug resistance, durable efficacy, and cure: how advanced biological insights and emerging drug modalities could transform progress. Expert opinion on therapeutic targets 26 (6) (2022)
Rosamaria Lappano, Damiano Cosimo Rigiracciolo, Ernestina Marianna De Francesco, Marcello Maggiolini, Ernestina Marianna De Francesco
Cancer associated fibroblasts: role in breast cancer and potential as therapeutic targets. Expert opinion on therapeutic targets 24 (6) (2020)
Rosamaria Lappano, Rosamaria Lappano
Pharmacotherapeutic Targeting of G Protein-Coupled Receptors in Oncology: Examples of Approved Therapies and Emerging Concepts. Drugs 77 (9) (2017)